1. The Impact of High-Flow Nasal Cannula Use on Patient Mortality and the Availability of Mechanical Ventilators in COVID-19
- Author
-
Yue Hu, Michelle N. Gong, Jing Dong, Carri W. Chan, Hayley B. Gershengorn, S. Jean Hsieh, and Jen Ting Chen
- Subjects
Adult ,Male ,Pulmonary and Respiratory Medicine ,Adolescent ,Critical Care ,high-flow nasal cannula ,Coronavirus disease 2019 (COVID-19) ,medicine.medical_treatment ,mechanical ventilation ,medicine.disease_cause ,Young Adult ,Mechanical ventilator ,medicine ,Cannula ,Humans ,Intubation ,Computer Simulation ,National level ,Hospital Mortality ,Letters ,Aged ,Original Research ,Mechanical ventilation ,Ventilators, Mechanical ,business.industry ,Oxygen Inhalation Therapy ,COVID-19 ,Middle Aged ,simulation ,Respiration, Artificial ,United States ,Respiratory support ,Hospitalization ,Survival Rate ,Treatment Outcome ,Anesthesia ,Female ,business ,High flow ,Nasal cannula ,Procedures and Techniques Utilization - Abstract
Rationale: How to provide advanced respiratory support for coronavirus disease (COVID-19) to maximize population-level survival while optimizing mechanical ventilator access is unknown. Objectives: To evaluate the use of high-flow nasal cannula for COVID-19 on population-level mortality and ventilator availability. Methods: We constructed dynamical (deterministic) simulation models of high-flow nasal cannula and mechanical ventilation use for COVID-19 in the United States. Model parameters were estimated through consensus based on published literature, local data, and experience. We had the following two outcomes: 1) cumulative number of deaths and 2) days without any available ventilators. We assessed the impact of various policies for the use of high-flow nasal cannula (with or without “early intubation”) versus a scenario in which high-flow nasal cannula was unavailable. Results: The policy associated with the fewest deaths and the least time without available ventilators combined the use of high-flow nasal cannula for patients not urgently needing ventilators with the use of early mechanical ventilation for these patients when at least 10% of ventilator supply was not in use. At the national level, this strategy resulted in 10,000–40,000 fewer deaths than if high-flow nasal cannula were not available. In addition, with moderate national ventilator capacity (30,000–45,000 ventilators), this strategy led to up to 25 (11.8%) fewer days without available ventilators. For a 250-bed hospital with 100 mechanical ventilators, the availability of 13, 20, or 33 high-flow nasal cannulas prevented 81, 102, and 130 deaths, respectively. Conclusions: The use of high-flow nasal cannula coupled with early mechanical ventilation when supply is sufficient results in fewer deaths and greater ventilator availability.
- Published
- 2021
- Full Text
- View/download PDF